NEW YORK – Siemens Healthineers has been granted funding from the Gates Foundation to support development of a maternal health screening tool, the firm announced on Friday. The total amount of the ...

Altai Capital said last month it had "serious concerns about the company’s significant share price underperformance." ...

The Spanish company will use the funding to accelerate the clinical transition of its LiverAce Combo assay for drug-induced liver injury assessment.

In a presentation, executives discussed upcoming data readouts and their potential effect on reimbursement for the firm's FirstLook Lung test.

The firm's CEO expects lab capital expenditures to return to normal by the second half of 2026 as the overall life science ...

The bill was one of several discussed during a Thursday hearing by the Health Subcommittee of the House of Representatives' ...

The firm said preliminary full-year 2025 revenue increased 17 percent to 18 percent year over year, with revenue from multi-cancer early detection blood test Galleri growing 25 to 26 percent.

Chairman and CEO Adam Schechter said that deals may open up as hospital systems grow concerned about Medicaid cuts and the end of Affordable Care Act subsidies.

Diagnostics is already operating somewhat separately from the firm's other two business units under its new organizational structure, company officials said.

President and CEO Jim Davis said he believes PAMA reform will pass this year but said another temporary delay will likely be needed to postpone cuts slated for February 1.

The company said it will use the money raised from a convertible notes offering to advance its proteomics platform.

NEW YORK — Point-of-care testing firm Truvian Health said on Monday that nine tests that run on its TruVerus benchtop blood analyzer have received 510(k) clearances from the US Food and Drug ...